SABS
Price
$2.04
Change
-$0.06 (-2.86%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
21.86M
TECX
Price
$15.18
Change
+$0.47 (+3.20%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
275.26M
Interact to see
Advertisement

SABS vs TECX

Header iconSABS vs TECX Comparison
Open Charts SABS vs TECXBanner chart's image
SAB Biotherapeutics
Price$2.04
Change-$0.06 (-2.86%)
Volume$2.2K
Capitalization21.86M
Tectonic Therapeutic
Price$15.18
Change+$0.47 (+3.20%)
Volume$10.34K
Capitalization275.26M
SABS vs TECX Comparison Chart in %
Loading...
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SABS vs. TECX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SABS is a Hold and TECX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (SABS: $2.04 vs. TECX: $15.18)
Brand notoriety: SABS and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SABS: 37% vs. TECX: 99%
Market capitalization -- SABS: $21.86M vs. TECX: $275.26M
SABS [@Biotechnology] is valued at $21.86M. TECX’s [@Biotechnology] market capitalization is $275.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SABS’s FA Score shows that 0 FA rating(s) are green whileTECX’s FA Score has 1 green FA rating(s).

  • SABS’s FA Score: 0 green, 5 red.
  • TECX’s FA Score: 1 green, 4 red.
According to our system of comparison, SABS is a better buy in the long-term than TECX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SABS’s TA Score shows that 5 TA indicator(s) are bullish while TECX’s TA Score has 4 bullish TA indicator(s).

  • SABS’s TA Score: 5 bullish, 6 bearish.
  • TECX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both SABS and TECX are a bad buy in the short-term.

Price Growth

SABS (@Biotechnology) experienced а -17.61% price change this week, while TECX (@Biotechnology) price change was +1.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECX($275M) has a higher market cap than SABS($21.9M). SABS YTD gains are higher at: -46.365 vs. TECX (-67.122). SABS has higher annual earnings (EBITDA): -33.47M vs. TECX (-63.29M). TECX has more cash in the bank: 287M vs. SABS (5.71M). TECX has less debt than SABS: TECX (1.94M) vs SABS (6.42M). SABS (0) and TECX (0) have equivalent revenues.
SABSTECXSABS / TECX
Capitalization21.9M275M8%
EBITDA-33.47M-63.29M53%
Gain YTD-46.365-67.12269%
P/E RatioN/A3.55-
Revenue00-
Total Cash5.71M287M2%
Total Debt6.42M1.94M330%
TECHNICAL ANALYSIS
Technical Analysis
SABSTECX
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
71%
Bullish Trend 16 days ago
90%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
60%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LNZNF30.30N/A
N/A
Lenzing AG
SLGYF0.30N/A
N/A
San Leon Energy Plc
KOBNF29.57N/A
N/A
Kobe Bussan Co., Ltd.
UCBJF240.27N/A
N/A
UCB S.A.
ZOONF0.01N/A
N/A
ZOONO GROUP LTD.

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with LPTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then LPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
-3.10%
LPTX - SABS
47%
Loosely correlated
-0.61%
MGX - SABS
36%
Loosely correlated
-0.43%
VERU - SABS
31%
Poorly correlated
+5.01%
TECX - SABS
28%
Poorly correlated
+3.20%
SLS - SABS
28%
Poorly correlated
+0.62%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IMNM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
+3.20%
IMNM - TECX
35%
Loosely correlated
+14.13%
ATHE - TECX
35%
Loosely correlated
-1.55%
DNA - TECX
34%
Loosely correlated
+2.18%
TRDA - TECX
33%
Loosely correlated
+3.94%
KYMR - TECX
33%
Poorly correlated
+4.75%
More